Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Smit

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Leukemia|October 29, 2004
Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomasK L Wu, H H Helgason, B van der Holt, et al.
The Netherlands Journal of Medicine|May 17, 2006
Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinomaS Corporaal, W M Smit, M G V M Russel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
A phase II trial of ZD0473 in platinum-pretreated ovarian cancerM E Gore, R J Atkinson, H Thomas, et al.
Leukemia|April 30, 2004
Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapyM Hoogendoorn, J Olde Wolbers, W M Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2003
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free intervalM E Gore, R J Atkinson, H Thomas, et al.
Human Immunology|April 1, 1997
Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cellsW M Smit, M Rijnbeek, C A van Bergen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationJ H Falkenburg, L M Faber, M van den Elshout, et al.
Investigational New Drugs|September 13, 2015
Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancerR van der Noll, W M Smit, A N M Wymenga, et al.
Blood|August 10, 1999
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytesJ H Falkenburg, A R Wafelman, P Joosten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2006
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancerS Rodenhuis, M Bontenbal, Q G C M van Hoesel, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Leukemia|October 29, 2004
Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomasK L Wu, H H Helgason, B van der Holt, et al.
The Netherlands Journal of Medicine|May 17, 2006
Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinomaS Corporaal, W M Smit, M G V M Russel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
A phase II trial of ZD0473 in platinum-pretreated ovarian cancerM E Gore, R J Atkinson, H Thomas, et al.
Leukemia|April 30, 2004
Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapyM Hoogendoorn, J Olde Wolbers, W M Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2003
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free intervalM E Gore, R J Atkinson, H Thomas, et al.
Human Immunology|April 1, 1997
Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cellsW M Smit, M Rijnbeek, C A van Bergen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationJ H Falkenburg, L M Faber, M van den Elshout, et al.
Investigational New Drugs|September 13, 2015
Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancerR van der Noll, W M Smit, A N M Wymenga, et al.
Blood|August 10, 1999
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytesJ H Falkenburg, A R Wafelman, P Joosten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2006
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancerS Rodenhuis, M Bontenbal, Q G C M van Hoesel, et al.
Pageof 3